New Zealand markets close in 6 hours 33 minutes

PFE Jan 2024 35.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
2.9900+0.5900 (+24.58%)
As of 03:10PM EDT. Market open.
Full screen
Previous close2.4000
Open2.5000
Bid2.9600
Ask3.0000
Strike35.00
Expiry date2024-01-19
Day's range2.4500 - 2.9900
Contract rangeN/A
Volume366
Open interest44.08k
  • Motley Fool

    3 Bargain Stocks to Buy in a Market That's Priced for Perfection

    Stock valuations are at historically high levels. Three Motley Fool contributors identified bargain stocks to buy in a market that's priced for perfection. Here's why they picked AbbVie (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Pfizer (NYSE: PFE).

  • Motley Fool

    2 Dividend Growth Stocks to Buy Right Now

    Dividends are great. They're a reliable source of passive income for retirees (and others) or can help boost long-term returns for investors who choose to reinvest them. But what happens when a company decreases or suspends its payouts? No investor wants to run into this problem.

  • Motley Fool

    With New COVID-19 Boosters in Tow, Which Is the Better Buy: Pfizer, BioNtech, or Moderna Stock?

    The Food and Drug Administration (FDA) just approved the updated Omicron-adapted COVID-19 booster shots from Moderna (NASDAQ: MRNA) and the COVID-19 booster that Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) collaborated on. While the news will certainly help the pharmaceutical companies' bottom lines, it's important to look deeper to see if any of these three stocks make a solid investment today. At first glance, Pfizer's stock appears to be a screaming deal.